ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

UT Health Science Center dedicates new Children’s Cancer Research Institute.

March 12, 2004

Contracts Cutback Canceled 7 RFPs

August 8, 1980